CIK 0000914475 · Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330525145
- Phone
- (858) 617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-31 | ROBERTS EIRY Chief Medical Officer | Sale 10b5-1 | −1,457 | $152.80 | $223K | 32,373 |
| 2025-01-31 | ROBERTS EIRY Chief Medical Officer | Option exercise · Restricted Stock Unit 10b5-1 | −2,769 | 2,769 | ||
| 2025-01-31 | Onyia Jude Chief Scientific Officer | Option exercise 10b5-1 | +238 | 15,687 | ||
| 2025-01-31 | Onyia Jude Chief Scientific Officer | Sale 10b5-1 | −126 | $152.97 | $19K | 15,561 |
| 2025-01-31 | Onyia Jude Chief Scientific Officer | Option exercise · Restricted Stock Unit 10b5-1 | −238 | 238 | ||
| 2025-01-31 | Lippoldt Darin Chief Legal Officer | Option exercise 10b5-1 | +2,373 | 42,113 | ||
| 2025-01-31 | Lippoldt Darin Chief Legal Officer | Sale 10b5-1 | −1,250 | $152.91 | $191K | 40,863 |
| 2025-01-31 | Lippoldt Darin Chief Legal Officer | Option exercise · Restricted Stock Unit 10b5-1 | −2,373 | 2,373 | ||
| 2025-01-31 | Gano Kyle Chief Executive Officer | Option exercise 10b5-1 | +2,927 | 138,319 | ||
| 2025-01-31 | Gano Kyle Chief Executive Officer | Sale 10b5-1 | −1,541 | $152.87 | $236K | 136,778 |
| 2025-01-31 | Gano Kyle Chief Executive Officer | Option exercise · Restricted Stock Unit 10b5-1 | −2,927 | 2,927 | ||
| 2025-01-31 | Delaet Ingrid Chief Regulatory Officer | Option exercise 10b5-1 | +801 | 3,308 | ||
| 2025-01-31 | Delaet Ingrid Chief Regulatory Officer | Sale 10b5-1 | −422 | $153.05 | $65K | 2,886 |
| 2025-01-31 | Delaet Ingrid Chief Regulatory Officer | Option exercise · Restriced Stock Unit 10b5-1 | −801 | 801 | ||
| 2025-01-31 | Boyer David W. Chief Corp. Affairs Officer | Option exercise 10b5-1 | +2,096 | 2,473 | ||
| 2025-01-31 | Boyer David W. Chief Corp. Affairs Officer | Sale 10b5-1 | −1,104 | $152.94 | $169K | 1,369 |
| 2025-01-31 | Boyer David W. Chief Corp. Affairs Officer | Option exercise · Restriced Stock Unit 10b5-1 | −2,096 | 2,096 | ||
| 2025-01-31 | BENEVICH ERIC Chief Commercial Officer | Option exercise 10b5-1 | +2,294 | 43,126 | ||
| 2025-01-31 | BENEVICH ERIC Chief Commercial Officer | Sale 10b5-1 | −1,207 | $152.94 | $185K | 41,919 |
| 2025-01-31 | BENEVICH ERIC Chief Commercial Officer | Option exercise · Restricted Stock Unit 10b5-1 | −2,294 | 2,294 |
Page 26 of 49 · 963 trades